Evidence map›Paper›PMID 42433659›Full record

ArticleNature reviews. Psychology2025

Negative affectivity drivers of impulsivity in opioid use disorder.

Jasmin Vassileva, Elena Psederska, James M Bjork

Abstract read
In one paragraph

Article in Nature reviews. Psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Functional connectivity in resting-state fMRI (rs-fMRI) in opioid use disorder.The European physical journal. Special topics · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jasmin VassilevaDepartment of Psychiatry, Virginia Commonwealth University, Richmond, VA, USA.
Elena PsederskaDepartment of Cognitive Science and Psychology, New Bulgarian University, Sofia, Bulgaria.
James M BjorkDepartment of Psychiatry, Virginia Commonwealth University, Richmond, VA, USA.

Funding

Varieties of Impulsivity in Opiate and Stimulant UsersR01DA021421 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI VASSILEVA, JASMIN L · 2008 to 2025
$6.5M
Utility of adaptive design optimization for developing rapid and reliable behavioral paradigms for substance use disordersR01DA058038 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI Woo-Young Ahn, JASMIN L VASSILEVA · 2023 to 2026
$2.1M
Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use DisorderU01DA057846 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI ARIAS, ALBERT JOSEPH, BJORK, JAMES M · 2022 to 2022
$1.6M
NIDA NIH HHS R01 DA021421NIDA NIH HHS R01 DA058038NIDA NIH HHS U01 DA057846
6 · The paper itself

Abstract

Despite the unprecedented toll of the opioid epidemic in the United States, the neurobehavioral features of opioid use disorder remain substantially understudied. Impulsivity plays a central role in substance use disorders, but might not be as prominent in opioid addiction. Impulsivity has multiple dimensions, related to stability and change (trait versus state) and emotion (emotion-elicited versus emotion-neutral). In this Review, we suggest that trait and state impulsivity in opioid use disorder is primarily emotion-elicited and mediated by negative reinforcement mechanisms that aim to relieve opioid users from acute or protracted opioid withdrawal or chronic negative affective states (for example, physical or emotional pain). Indeed, negative reinforcement mechanisms are involved in all stages of the opioid addiction cycle and are more heavily implicated in opioid use than in other substance use. Moreover, we identify that impulsive behavior in opioid use disorder frequently occurs in the context of negative affectivity manifested as a personality trait (such as negative urgency) or a personality disorder (such as psychopathy), which are less common in other substance use disorders. Further examination of these mechanisms will deepen current knowledge of the neurobehavioral underpinnings of opioid addiction and improve clinical treatment.

Identifiers

PMID42433659
PMCPMC13353541

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.